Dexamethasone-d3-1 is a deuterium-labeled Dexamethasone. It acts as a glucocorticoid receptor agonist and is known to decrease CD11b, CD18, and CD62L expression on neutrophils, as well as CD11b and CD18 expression on monocytes. This compound is intended for research use only and can be utilized as a tracer or an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
- Effective in controlling COVID-19 infection
- Inhibits the production of exosomes containing inflammatory microRNA-155 in lipopolysaccharide-induced macrophage inflammatory responses